Hyperfine, Inc. (HYPR) Reports Q2 Loss, Tops Revenue Estimates

Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of$0.15 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this company would post a loss of $0.14 per share when it actually produced a loss of$0.14, delivering no surprise. Over the last four quarters, the company has surpassed consensus EPS estimates just once. Hyperfine, which belongs to the Zacks Medical - ...